VEGFR-3 ligand-binding and kinase activity are required for lymphangiogenesis but not for angiogenesis
about
The cellular response to vascular endothelial growth factors requires co-ordinated signal transduction, trafficking and proteolysisDevelopment of the mammalian lymphatic vasculatureEndothelial tip cells in ocular angiogenesis: potential target for anti-angiogenesis therapyLymph flow regulates collecting lymphatic vessel maturation in vivo.Biological functions of macrophage-derived Wnt5a, and its roles in human diseasesDietary compound isoliquiritigenin inhibits breast cancer neoangiogenesis via VEGF/VEGFR-2 signaling pathwayLymphatic function is required prenatally for lung inflation at birth.The Prox1-Vegfr3 feedback loop maintains the identity and the number of lymphatic endothelial cell progenitorsPyogenic granuloma, an impaired wound healing process, linked to vascular growth driven by FLT4 and the nitric oxide pathway.Ras/MAPK signaling modulates VEGFR-3 expression through Ets-mediated p300 recruitment and histone acetylation on the Vegfr3 gene in lymphatic endothelial cells.Lymphatic vascular morphogenesis in development, physiology, and diseaseVEGFR-3 controls tip to stalk conversion at vessel fusion sites by reinforcing Notch signalling.A small molecular agent YL529 inhibits VEGF-D-induced lymphangiogenesis and metastasis in preclinical tumor models in addition to its known antitumor activities.miR-27b controls venous specification and tip cell fateRole of bone marrow-derived lymphatic endothelial progenitor cells for lymphatic neovascularization.Molecular regulation of lymphangiogenesis in development and tumor microenvironment.Endothelial ERK signaling controls lymphatic fate specificationThe secreted lymphangiogenic factor CCBE1 is essential for fetal liver erythropoiesisNovel application assigned to toluquinol: inhibition of lymphangiogenesis by interfering with VEGF-C/VEGFR-3 signalling pathway.Angiogenesis-related pathways in the pathogenesis of ovarian cancerAutocrine VEGFR1 and VEGFR2 signaling promotes survival in human glioblastoma models in vitro and in vivoCarbohydrate-binding protein CLEC14A regulates VEGFR-2- and VEGFR-3-dependent signals during angiogenesis and lymphangiogenesis.Interaction of tumor cells and lymphatic vessels in cancer progression.Mechanical forces in lymphatic vascular development and disease.VEGFR signaling during lymphatic vascular development: From progenitor cells to functional vessels.Why increased nuchal translucency is associated with congenital heart disease: a systematic review on genetic mechanisms.CD146 is required for VEGF-C-induced lymphatic sprouting during lymphangiogenesis.Modulation of VEGF-induced migration and network formation by lymphatic endothelial cells: Roles of platelets and podoplanin.The lymphatic vasculature: development and role in shaping immunity.An orally administered DNA vaccine targeting vascular endothelial growth factor receptor-3 inhibits lung carcinoma growth.Kallistatin inhibits lymphangiogenesis and lymphatic metastasis of gastric cancer by downregulating VEGF-C expression and secretion.Lymphangiogenesis guidance by paracrine and pericellular factors.
P2860
Q26796921-35B605B5-BD6F-4C36-962C-12B5BA892A75Q26852649-B2A39BD6-ECA3-484B-B224-17E5AE1D2A57Q26865091-2CFE1465-C97D-4360-AE57-2A2102561E11Q27332557-F23E0FE8-A4C3-4DFA-A652-39FDC7E0EF68Q28079931-1D3D7D92-25F6-4B45-BE68-8F6B442658A0Q28385231-CDCC5CE5-2B9F-4B51-B967-AFF9F4D4CE34Q28505708-CBE5C959-4213-4D16-BADA-8621B9C0084BQ34271373-B5796E77-2BB7-409E-8454-2054BBB6BE97Q34407465-3FEA6074-F22B-4835-AD6A-529AF0EDA98EQ34532103-00E071D8-9A5B-48F4-A60C-BFF3E63E082BQ35196040-F9292D43-B384-44F7-A406-293F25F7044BQ35682284-AD3C52B8-9626-4076-855C-A69A1188342FQ35695806-B23641AE-D437-4E75-815E-6C95669FF3EDQ35849356-7C1389B1-B08A-47AC-A912-DB042BB65950Q36062311-B44DA443-9128-4C42-A4C4-9A9318A2B25EQ36284953-BEB6D5E1-EA73-4629-B326-D756975DFEE5Q36638093-60D6715A-E17A-4657-90CA-794B6DC9B155Q36849028-B68D8E3D-5C2C-418B-A70E-D1B3C02E11DDQ36941258-6740D1CA-047D-46FF-9B98-6B28282DD79AQ37139109-FCB0EE2F-ADAB-44F2-AFB5-06A45E1C9E5DQ37207348-E09625EC-2B2C-432B-81B3-0E5997ED1311Q37610682-386BC133-D8E5-419B-943D-FA9654F93272Q37969667-DB7E83E8-7765-43FF-B614-E779D09AEB3FQ38105904-92EA0E5C-1CBF-4C79-B345-9EFC7C583E46Q38268530-4EC49A9A-5BB8-404B-B5AE-2F5CA24CD865Q38366535-884AB67F-DDBE-4CA9-90DE-B4FB9116696BQ38636009-D43C8B8F-A324-47BD-B4E0-83D8CEC90058Q38670274-5A0C98C6-8816-4DEB-86B6-C2CAFCDD12D2Q38810930-5C2C12DC-9B56-4B20-A434-8677E94D11CBQ38834918-7D057862-438E-4B99-AC34-AB6E9A54A6E1Q47247582-37B3F545-5A32-4C6D-939A-28DD603AD4E0Q47744569-D9E0259F-9EB8-4CF9-A647-8988011D7E85
P2860
VEGFR-3 ligand-binding and kinase activity are required for lymphangiogenesis but not for angiogenesis
description
2010 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
artículu científicu espublizáu en 2010
@ast
im Dezember 2010 veröffentlichter wissenschaftlicher Artikel
@de
scientific journal article
@en
vedecký článok (publikovaný 2010/12/01)
@sk
vědecký článek publikovaný v roce 2010
@cs
wetenschappelijk artikel (gepubliceerd op 2010/12/01)
@nl
наукова стаття, опублікована в грудні 2010
@uk
مقالة علمية (نشرت في ديسمبر 2010)
@ar
name
VEGFR-3 ligand-binding and kin ...... nesis but not for angiogenesis
@ast
VEGFR-3 ligand-binding and kin ...... nesis but not for angiogenesis
@en
VEGFR-3 ligand-binding and kin ...... nesis but not for angiogenesis
@nl
type
label
VEGFR-3 ligand-binding and kin ...... nesis but not for angiogenesis
@ast
VEGFR-3 ligand-binding and kin ...... nesis but not for angiogenesis
@en
VEGFR-3 ligand-binding and kin ...... nesis but not for angiogenesis
@nl
prefLabel
VEGFR-3 ligand-binding and kin ...... nesis but not for angiogenesis
@ast
VEGFR-3 ligand-binding and kin ...... nesis but not for angiogenesis
@en
VEGFR-3 ligand-binding and kin ...... nesis but not for angiogenesis
@nl
P2093
P921
P3181
P356
P1433
P1476
VEGFR-3 ligand-binding and kin ...... nesis but not for angiogenesis
@en
P2093
Jincai Luo
Luqing Zhang
Masabumi Shibuya
Wencan Han
P2860
P2888
P304
P3181
P356
10.1038/CR.2010.116
P577
2010-12-01T00:00:00Z
P5875
P6179
1046436876